Provided by Tiger Fintech (Singapore) Pte. Ltd.

GRACE THERAPEUTICS INC

2.18
-0.1100-4.80%
Post-market: 2.180.00000.00%19:59 EDT
Volume:55.08K
Turnover:120.30K
Market Cap:29.25M
PE:-1.88
High:2.26
Open:2.24
Low:2.07
Close:2.29
Loading ...

Company Profile

Company Name:
GRACE THERAPEUTICS INC
Exchange:
NASDAQ
Establishment Date:
2002
Employees:
32
Office Location:
103 Carnegie Center,Suite 300,Princeton,New Jersey,United States
Zip Code:
08540
Fax:
- -
Introduction:
Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Directors

Name
Position
Prashant Kohli
Director and Chief Executive Officer
Vimal Kavuru
Director and Chairman of the Board
A. Brian Davis
Director
Edward Neugeboren
Director
S. George Kottayil
Director

Shareholders

Name
Position
Prashant Kohli
Director and Chief Executive Officer
Brian Ford
Interim Chief Financial Officer
Amresh Kumar
VP of Program Management
Carrie D'Andrea
VP Clinical Operations
R. Loch Macdonald
Chief Medical Officer